JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
JAK2-V617F promotes venous thrombosis through β1/β2 integrin activation
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
American Society for Clinical Investigation
Online
2018-07-20
DOI
10.1172/jci90312
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
- (2018) Ofir Wolach et al. Science Translational Medicine
- Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods
- (2017) Franca Marino et al. JOURNAL OF IMMUNOLOGICAL METHODS
- JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1
- (2017) N Gupta et al. LEUKEMIA
- Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells
- (2017) Marcello Monti et al. PLoS One
- Regulation of tissue infiltration by neutrophils
- (2016) Pallavi Subramanian et al. CURRENT OPINION IN HEMATOLOGY
- Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion
- (2016) Lijuan Han et al. Journal of Hematology & Oncology
- Neutrophil-derived chemokines on the road to immunity
- (2016) Cristina Tecchio et al. SEMINARS IN IMMUNOLOGY
- Macrophages retain hematopoietic stem cells in the spleen via VCAM-1
- (2015) Partha Dutta et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease
- (2015) Ioannis Mitroulis et al. PHARMACOLOGY & THERAPEUTICS
- JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
- (2015) M. Kleppe et al. Cancer Discovery
- Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke
- (2014) Jens Neumann et al. ACTA NEUROPATHOLOGICA
- Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm
- (2014) L. Lamrani et al. BLOOD
- Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
- (2014) R. Rampal et al. BLOOD
- Epo-induced erythroid maturation is dependent on Plcγ1 signaling
- (2014) T M Schnöder et al. CELL DEATH AND DIFFERENTIATION
- Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressingJAK2-V617F
- (2014) Pontus Lundberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Serine/Threonine Kinase Ndr2 Controls Integrin Trafficking and Integrin-Dependent Neurite Growth
- (2014) K. Rehberg et al. JOURNAL OF NEUROSCIENCE
- SPECT-imaging of activity-dependent changes in regional cerebral blood flow induced by electrical and optogenetic self-stimulation in mice
- (2014) Angela Kolodziej et al. NEUROIMAGE
- JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
- (2014) S. Leah Etheridge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of the guanine-nucleotide-exchange factor CalDAG-GEFI by protein kinase A regulates Ca2+-dependent activation of platelet Rap1b GTPase
- (2013) Gianni Francesco Guidetti et al. BIOCHEMICAL JOURNAL
- JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia
- (2013) C. M. Hobbs et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Thrombosis: tangled up in NETs
- (2013) K. Martinod et al. BLOOD
- JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation
- (2013) Alessio Montresor et al. JOURNAL OF CELL BIOLOGY
- The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML
- (2013) Florian H. Heidel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PI3-Kinase γ Promotes Rap1a-Mediated Activation of Myeloid Cell Integrin α4β1, Leading to Tumor Inflammation and Growth
- (2013) Michael C. Schmid et al. PLoS One
- JAK2V617F activates Lu/BCAM-mediated red cell adhesion in polycythemia vera through an EpoR-independent Rap1/Akt pathway
- (2012) M. De Grandis et al. BLOOD
- Dysfunction of the PI3 kinase/Rap1/integrin IIb 3 pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia
- (2012) S. F. Moore et al. BLOOD
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
- (2012) Marie-Luise von Brühl et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition
- (2012) Sonam Prakash et al. MODERN PATHOLOGY
- Neutrophil infiltration during inflammation is regulated by PILRα via modulation of integrin activation
- (2012) Jing Wang et al. NATURE IMMUNOLOGY
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- CCR7-mediated LFA-1 functions in T cells are regulated by 2 independent ADAP/SKAP55 modules
- (2011) S. Kliche et al. BLOOD
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
- (2011) Alfonso Quintás-Cardama et al. NATURE REVIEWS DRUG DISCOVERY
- Rapid Immunomagnetic Negative Enrichment of Neutrophil Granulocytes from Murine Bone Marrow for Functional Studies In Vitro and In Vivo
- (2011) Mike Hasenberg et al. PLoS One
- Vascular Cell Adhesion Molecule-1 Expression and Signaling During Disease: Regulation by Reactive Oxygen Species and Antioxidants
- (2010) Joan M. Cook-Mills et al. ANTIOXIDANTS & REDOX SIGNALING
- Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
- (2010) C. Marty et al. BLOOD
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
- (2010) Ann Mullally et al. CANCER CELL
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- CalDAG-GEFI and platelet activation
- (2010) Lucia Stefanini et al. PLATELETS
- Blood cell activation in myeloproliferative neoplasms
- (2009) F. Cervantes et al. HAEMATOLOGICA
- Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
- (2009) Federico Lussana et al. THROMBOSIS RESEARCH
- Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence andJAK2 V617F allele burden
- (2008) Eduardo Arellano-Rodrigo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
- (2008) F. Passamonti et al. HAEMATOLOGICA
- Mechanisms and Consequences of Neutrophil Interaction with the Endothelium
- (2007) Alexander Zarbock et al. AMERICAN JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now